Subscribe To
Sec charges crypto firms genesis and gemini over sale of unregistered securities
SEC charges crypto firms Genesis and Gemini over sale of unregistered securities Read Full Story The po...
January 12, 2023, 10:12 pm
Us sec charges individuals behind $45m blockchain fraud coindeal
The US ...
January 5, 2023, 11:16 am
Coinbase stock down 21% on sec probe
The SEC is probing Coinbase for allegedly allowing the trading of unregistered securities....
July 26, 2022, 5:10 pm
Coinbase reportedly subject to sec investigation into unregistered securities
US regulator the Securities Exchange Commission (SEC) has opened a probe into NASDAQ-listed cryptocurrency exchange Coinbase, a Bloomberg report has r...
July 26, 2022, 6:25 am
Sec reportedly investigating coinbase over crypto trading
The Securities and Exchange Commission is reportedly investigating Coinbase Global Inc. over whether it has allowed the trading of ...
July 25, 2022, 9:30 pm
Voyager digital's crypto interest accounts in state regulators' crosshairs
Voyager Digital is the latest crypto exchange under siege for its interest-bearing crypto accounts, with regulators from seven states either demanding...
March 30, 2022, 3:50 pm
Neurobo pharmaceuticals closes $14 million registered direct offering
BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and ...
October 5, 2021, 1:13 pm
Neurobo pharmaceuticals closes $14 million registered direct offering
BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and ...
October 5, 2021, 1:13 pm
Neurobo pharmaceuticals closes $14 million registered direct offering
BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and ...
October 5, 2021, 1:13 pm
Neurobo pharmaceuticals closes $14 million registered direct offering
BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and ...
October 5, 2021, 1:13 pm
Neurobo pharmaceuticals closes $14 million registered direct offering
BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and ...
October 5, 2021, 1:13 pm
Neurobo pharmaceuticals closes $14 million registered direct offering
BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and ...
October 5, 2021, 1:13 pm
Neurobo pharmaceuticals closes $14 million registered direct offering
BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and ...
October 5, 2021, 1:13 pm